Thrombectomy is the surgical removal of blood clot from a blood vessel. Deep vein thrombosis is a life-threatening disease where blood clots within a vein. These clots can pass through to arteries or veins in different body parts—brain, heart, kidneys, lungs, and limbs. Similarly, venous thromboembolism (VTE) is considered as the cause of heart attack and stroke; however, it can damage body organs or may even lead to death. VTE results due to various factors such as combination of hereditary and acquired risk factors. It can be diagnosed in smoking population and people who consume estrogens or birth control pills. VTE is highly prevalent in adults (>60 years), however, can occur at any age.
The U.S. thrombectomy devices market is was valued at $501.9 million in 2017, and is estimated to garner $750.4 million by 2025, registering a significant CAGR of 5.1% from 2018 to 2025. This is attributed to increase in incidence of acute myocardial infarction (AMI), peripheral artery disease (PAD), deep vein thrombosis (DVT), and pulmonary embolism (PE), due to sedentary lifestyle and unhealthy living conditions & habits along with rise in geriatric population in the U.S. Moreover, increase in incidence of cardiovascular diseases, surge in demand for minimally invasive procedures, rise in need for sophisticated healthcare infrastructure; and increase in market competition have led to technological advancements and innovations. However, lack of trained professionals & awareness and complicated use of these devices restrict the market growth. On the contrary, introduction of lasers & UV radiation and 3D imaging generation in thrombectomy devices is anticipated to provide lucrative growth opportunities to market players in the near future.
The U.S. thrombectomy devices market is segmented based on technology, type, utility, and disease. Depending on the type of technology, the market is categorized into mechanical, aspiration, and rheolytic thrombectomy devices. By type, it is bifurcated into automated and manual thrombectomy devices. As per utility, it is classified into reusable and disposable thrombectomy devices. On the basis of disease, it is divided into peripheral, neurovascular, and coronary thrombectomy devices.
Key Benefits for U.S. Thrombectomy Devices Market:
The U.S. thrombectomy report provides an extensive analysis of the current market trends and future estimations of the market.
The market scenario is comprehensively analyzed with respect to the technology, type, utility, and disease.
The U.S. thrombectomy devices market growth estimations in this report are based on high-end analysis of the key developments for 2018–2025.
Recent developments, key manufacturers, and market shares are listed in this report to analyze the competitive scenario of the market.
U.S. Thrombectomy Devices Key Market Segments:
Mechanical Thrombectomy Devices
Aspiration Thrombectomy Devices
Rheolytic Thrombectomy Devices
Automated Thrombectomy Devices
Manual Thrombectomy Devices
Peripheral Thrombectomy Devices
Coronary Thrombectomy Devices
Neural Thrombectomy Devices
Reusable Thrombectomy Devices
Disposable Thrombectomy Devices
Key Market Players
Boston Scientific Corporation
Koninklijke Philips N.V.
Johnson and Johnson
Capture Vascular, Inc.
The other players in the value chain include (profiles not included in the report)
Argon Medical Devices, Inc.
Inari Medical, Inc."
Get a sample pages of this report Click here